Biogen Inc. buy Needham & Company LLC
Start price
01.08.24
/
50%
€198.10
Target price
01.08.25
€266.57
Performance (%)
-42.66%
End price
02.08.25
€113.60
Summary
This prediction ended on 02.08.25 with a price of €113.60. Massive losses of -42.66% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 3.296% | 3.296% | 50.228% |
| iShares Core DAX® | 1.598% | 5.040% | 3.870% |
| iShares Nasdaq 100 | 3.742% | 14.947% | 36.139% |
| iShares Nikkei 225® | 3.736% | 13.892% | 43.808% |
| iShares S&P 500 | 1.816% | 8.879% | 25.510% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $288.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten

